文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

树枝状大分子在医学应用中的安全挑战与应用策略

Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.

作者信息

Li Xiang, Naeem Abid, Xiao Shanghua, Hu Lei, Zhang Jing, Zheng Qin

机构信息

National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine, Nanchang 330006, China.

Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang 330004, China.

出版信息

Pharmaceutics. 2022 Jun 17;14(6):1292. doi: 10.3390/pharmaceutics14061292.


DOI:10.3390/pharmaceutics14061292
PMID:35745863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9230513/
Abstract

Dendrimers are used for a variety of applications in medicine but, due to their host-guest and entrapment characteristics, are particularly used for the delivery of genes and drugs. However, dendrimers are intrinsically toxic, thus creating a major limitation for their use in biological systems. To reduce such toxicity, biocompatible dendrimers have been designed and synthesized, and surface engineering has been used to create advantageous changes at the periphery of dendrimers. Although dendrimers have been reviewed previously in the literature, there has yet to be a systematic and comprehensive review of the harmful effects of dendrimers. In this review, we describe the routes of dendrimer exposure and their distribution in vivo. Then, we discuss the toxicity of dendrimers at the organ, cellular, and sub-cellular levels. In this review, we also describe how technology can be used to reduce dendrimer toxicity, by changing their size and surface functionalization, how dendrimers can be combined with other materials to generate a composite formulation, and how dendrimers can be used for the diagnosis of disease. Finally, we discuss future challenges, developments, and research directions in developing biocompatible and safe dendrimers for medical purposes.

摘要

树枝状大分子在医学中有多种应用,但由于其主客体和包封特性,特别用于基因和药物递送。然而,树枝状大分子具有内在毒性,因此在生物系统中的应用存在重大限制。为降低此类毒性,已设计并合成了生物相容性树枝状大分子,并采用表面工程在树枝状大分子的外围产生有利变化。尽管此前文献中已有关于树枝状大分子的综述,但尚未有对其有害影响进行系统全面的综述。在本综述中,我们描述了树枝状大分子的暴露途径及其在体内的分布。然后,我们讨论了树枝状大分子在器官、细胞和亚细胞水平的毒性。在本综述中,我们还描述了如何通过改变其大小和表面功能化来利用技术降低树枝状大分子的毒性,树枝状大分子如何与其他材料结合以生成复合制剂,以及树枝状大分子如何用于疾病诊断。最后,我们讨论了开发用于医学目的的生物相容性和安全树枝状大分子的未来挑战、发展和研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/c6147e7a6b9a/pharmaceutics-14-01292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/a5c1a0f1f7eb/pharmaceutics-14-01292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/4d8785fb8248/pharmaceutics-14-01292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/b2d4353e8801/pharmaceutics-14-01292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/c6147e7a6b9a/pharmaceutics-14-01292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/a5c1a0f1f7eb/pharmaceutics-14-01292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/4d8785fb8248/pharmaceutics-14-01292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/b2d4353e8801/pharmaceutics-14-01292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ed8/9230513/c6147e7a6b9a/pharmaceutics-14-01292-g004.jpg

相似文献

[1]
Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.

Pharmaceutics. 2022-6-17

[2]
Dendrimer toxicity: Let's meet the challenge.

Int J Pharm. 2010-4-28

[3]
Toxicity and Surface Modification of Dendrimers: A Critical Review.

Curr Drug Deliv. 2022

[4]
Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives.

Chem Soc Rev. 2011-2-1

[5]
PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.

Acta Biomater. 2016-10-1

[6]
Pharmaceutical and biomedical potential of surface engineered dendrimers.

Crit Rev Ther Drug Carrier Syst. 2007

[7]
Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticals.

Curr Pharm Des. 2009

[8]
Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targeting.

Eur J Pharm Sci. 2018-7-9

[9]
Dendrimer biocompatibility and toxicity.

Adv Drug Deliv Rev. 2005-12-14

[10]
Self-Assembling Supramolecular Dendrimers for Biomedical Applications: Lessons Learned from Poly(amidoamine) Dendrimers.

Acc Chem Res. 2020-12-15

引用本文的文献

[1]
Harnessing the Power of Nanocarriers to Exploit the Tumor Microenvironment for Enhanced Cancer Therapy.

Pharmaceuticals (Basel). 2025-5-19

[2]
Advances in nanomaterials for precision drug delivery: Insights into pharmacokinetics and toxicity.

Bioimpacts. 2024-11-2

[3]
Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies.

Biomolecules. 2025-3-1

[4]
Human Embryonic Kidney HEK293 Cells as a Model to Study SMVT-Independent Transport of Biotin and Biotin-Furnished Nanoparticles in Targeted Therapy.

Int J Mol Sci. 2025-2-13

[5]
Precision Therapy for Prostate Cancer: Advancements in Polymeric Nanocarrier Systems.

Anticancer Agents Med Chem. 2025-1-30

[6]
Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders.

Pharmaceuticals (Basel). 2025-1-13

[7]
Navigating liver cancer: Precision targeting for enhanced treatment outcomes.

Drug Deliv Transl Res. 2025-6

[8]
Comparative Study of Functionalized Carbosilane Dendrimers for siRNA Delivery: Synthesis, Cytotoxicity, and Biophysical Properties.

ACS Omega. 2024-12-20

[9]
Nanotechnology-Based Approaches for the Management of Diabetes Mellitus: An Innovative Solution to Long-Lasting Challenges in Antidiabetic Drug Delivery.

Pharmaceutics. 2024-12-9

[10]
How Dendrimers Impact Fibrin Clot Formation, Structure, and Properties.

ACS Omega. 2024-12-18

本文引用的文献

[1]
Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment.

Theranostics. 2022

[2]
An Overview of Nanotechnologies for Drug Delivery to the Brain.

Pharmaceutics. 2022-1-19

[3]
The effect of maltose modified fourth generation poly(propylene imine) (PPI G4) dendrimers on the barrier functions and inflammatory activation of human vascular endothelium - Possible consequences for the medical application.

Vascul Pharmacol. 2022-4

[4]
Synthesis of Biotinylated PAMAM G3 Dendrimers Substituted with -Glycidol and Celecoxib/Simvastatin as Repurposed Drugs and Evaluation of Their Increased Additive Cytotoxicity for Cancer Cell Lines.

Cancers (Basel). 2022-1-29

[5]
Ocular Nanomedicine.

Adv Sci (Weinh). 2022-5

[6]
Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and Worms.

Int J Mol Sci. 2021-11-29

[7]
Application of dendrimer-based nanosensors in immunodiagnosis.

Colloids Surf B Biointerfaces. 2022-1

[8]
Toxicity and Surface Modification of Dendrimers: A Critical Review.

Curr Drug Deliv. 2022

[9]
The role of the electrokinetic charge of neurotrophis-based nanocarriers: protein distribution, toxicity, and oxidative stress in in vitro setting.

J Nanobiotechnology. 2021-8-28

[10]
Unconventional Approaches to Prepare Triazine-Based Liquid Crystal Dendrimers.

Nanomaterials (Basel). 2021-8-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索